Resilience-h2020 12+
Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)
Designed for iPad
-
- Free
Screenshots
Description
RESILIENCE Proyect
A European Commission-funded project aimed at reducing the incidence of heart failure in cancer survivors
Cancer survivors are at high risk for cardiovascular complications. Anthracyclines are an extremely effective treatment against many cancer types, but they can induce cardiac toxicity resulting in chronic heart failure.
RESILIENCE Project tests a novel preventive intervention (remote ischemic conditioning) in patients at risk for anthracycline-induced cardiotoxicity. In addition, new diagnostic modalities will be used to identify anthracyclines-induced cardiotoxicity in its very early stages.
RESILIENCE counts on a multidisciplinary consortium with the active participation of patients.
What’s New
Version 1.0.2
Improvements and corrections
App Privacy
The developer, Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.), indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer's privacy policy.
Data Not Collected
The developer does not collect any data from this app.
Privacy practices may vary, for example, based on the features you use or your age. Learn More
Information
- Seller
- Centro Nacional de Investigaciones Cardiovasculares Carlos III F.S.P.
- Size
- 35 MB
- Category
- Medical
- Compatibility
-
- iPhone
- Requires iOS 12.0 or later.
- iPad
- Requires iPadOS 12.0 or later.
- iPod touch
- Requires iOS 12.0 or later.
- Mac
- Requires macOS 11.0 or later and a Mac with Apple M1 chip or later.
- Apple Vision
- Requires visionOS 1.0 or later.
- Languages
-
English, Spanish
- Age Rating
- 12+ Infrequent/Mild Medical/Treatment Information
- Copyright
- © 2020-2021 Centro Nacional de Investigaciones Cardiovasculares Carlos III (F.S.P.)
- Price
- Free